CVE-2025-61940
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Published:Dec 2, 2025
Last Modified:Jan 2, 2026
EPS:Dec 2, 2025
EPSS Score:0.00052
CVSS Score:8.3
Affected Products
Vendor
Product
Action
Vendor
Microsoft
Product
Windows
Microsoft
Windows
Vendor
Mirion
Product
Biodose\/nmis
Mirion
Biodose\/nmis
Vendor
Mirion Medical
Product
Nmis Biodose
Mirion Medical
Nmis Biodose
Exploits
No exploit reference
Common Weakness Enumeration
Common Attack Pattern Enumeration and Classification (CAPEC)
No CAPEC recorded yet
Related CVEs
Common Vulnerability Scoring System
Attack Vector
Network
Adjacent
Local
Physical
Privileges Required
None
Low
High
User Interaction
None
Required
Scope
Unchanged
Changed
Confidentiality
None
Low
High
Integrity
None
Low
High
Availability
None
Low
High
